Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $24.54 Analyst target: $27.67 Upside: 12.75%
STAAR Surgical Company designs, develops, manufactures, markets and sells implantable eye lenses and supplemental delivery systems for placing the lenses in the eye. The company is headquartered in Lake Forest, California.
See the full interactive analysis & chart →Informational only — not investment advice.